3 ms·There are similar drugs(eg osimertinib) for EGFR+ cancers, which are estimated to be 10-33% of NSCLC.by noncoml 2y agoThere are similar drugs(eg osimertinib) for EGFR+ cancers, which are estimated to be 10-33% of NSCLC.